Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study.

Kim SI, Choi CH, Kim K, Hong DH, Park JY, Kwon BS, Lee KH, Hong DG, Shin SJ, Park SI, Kim YH, Lee SH, Lee S, Hong JH, Lee JY, Kim YB, No JH, Suh DH.

J Obstet Gynaecol Res. 2019 Dec 9. doi: 10.1111/jog.14171. [Epub ahead of print]

PMID:
31814199
2.

The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.

Park JY, Park SK, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH.

Gynecol Oncol. 2011 Aug;122(2):255-9. doi: 10.1016/j.ygyno.2011.04.021. Epub 2011 May 12.

PMID:
21565389
3.

Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).

Hensley ML, Wathen JK, Maki RG, Araujo DM, Sutton G, Priebat DA, George S, Soslow RA, Baker LH.

Cancer. 2013 Apr 15;119(8):1555-61. doi: 10.1002/cncr.27942. Epub 2013 Jan 18.

4.

Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma.

Lin KH, Torng PL, Tsai KH, Shih HJ, Chen CL.

Taiwan J Obstet Gynecol. 2015 Apr;54(2):172-7. doi: 10.1016/j.tjog.2015.03.001.

5.

The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.

Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL.

Int J Gynecol Cancer. 2016 Jan;26(1):141-8. doi: 10.1097/IGC.0000000000000561.

PMID:
26509850
6.

Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.

George S, Barysauskas C, Serrano C, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Demetri GD, Muto MG.

Cancer. 2014 Oct 15;120(20):3154-8. doi: 10.1002/cncr.28844. Epub 2014 Jun 12.

7.

Options for Adjuvant Therapy for Uterine Leiomyosarcoma.

Friedman CF, Hensley ML.

Curr Treat Options Oncol. 2018 Feb 8;19(2):7. doi: 10.1007/s11864-018-0526-0. Review.

PMID:
29417238
8.

Uterine morcellation and survival in uterine sarcomas.

Bretthauer M, Goderstad JM, Løberg M, Emilsson L, Ye W, Adami HO, Kalager M.

Eur J Cancer. 2018 Sep;101:62-68. doi: 10.1016/j.ejca.2018.06.007. Epub 2018 Jul 17.

PMID:
30025231
9.

Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.

Raine-Bennett T, Tucker LY, Zaritsky E, Littell RD, Palen T, Neugebauer R, Axtell A, Schultze PM, Kronbach DW, Embry-Schubert J, Sundang A, Bischoff K, Compton-Phillips AL, Lentz SE.

Obstet Gynecol. 2016 Jan;127(1):29-39. doi: 10.1097/AOG.0000000000001187. Erratum in: Obstet Gynecol. 2016 Feb;127(2):405.

PMID:
26646120
10.

Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.

Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J.

Int J Gynecol Cancer. 2010 Aug;20(6):1000-5. doi: 10.1111/IGC.0b013e3181d80aff.

PMID:
20683408
11.

Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.

Loizzi V, Cormio G, Nestola D, Falagario M, Surgo A, Camporeale A, Putignano G, Selvaggi L.

Oncology. 2011;81(2):91-7. doi: 10.1159/000331679. Epub 2011 Oct 3.

PMID:
21968290
12.

The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.

Oduyebo T, Rauh-Hain AJ, Meserve EE, Seidman MA, Hinchcliff E, George S, Quade B, Nucci MR, Del Carmen MG, Muto MG.

Gynecol Oncol. 2014 Feb;132(2):360-5. doi: 10.1016/j.ygyno.2013.11.024. Epub 2013 Dec 1.

PMID:
24296345
13.

Impact of adjuvant treatment on oncologic outcomes in patients with stage I leiomyosarcoma of the uterus.

Boyraz G, Başaran D, Salman MC, Özgül N, Yüce K.

Turk J Med Sci. 2017 Jun 12;47(3):841-846. doi: 10.3906/sag-1603-135.

PMID:
28618731
14.

Clinical outcomes of adjuvant chemotherapy and vaginal brachytherapy with or without pelvic radiation for surgical stage I-II uterine serous carcinoma.

Robbins JR, Siddiqui MS, Al-Wahab Z, Laser B, Lu M, Ali-Fehmi R, Munkarah A, Elshaikh MA.

Eur J Gynaecol Oncol. 2012;33(5):449-54.

PMID:
23185785
15.

Effects of morcellation on long-term outcomes in patients with uterine leiomyosarcoma.

Nemec W, Inwald EC, Buchholz S, Klinkhammer Schalke M, Gerken M, Ortmann O.

Arch Gynecol Obstet. 2016 Oct;294(4):825-31. doi: 10.1007/s00404-016-4086-x. Epub 2016 Apr 22.

PMID:
27105972
16.

Uterine leiomyosarcoma: analysis of treatment failures and survival.

Gadducci A, Landoni F, Sartori E, Zola P, Maggino T, Lissoni A, Bazzurini L, Arisio R, Romagnolo C, Cristofani R.

Gynecol Oncol. 1996 Jul;62(1):25-32.

PMID:
8690287
17.

Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.

Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, Soslow RA, Juretzka MM, Chi DS, Barakat RR, Brennan MF, Hensley ML.

J Clin Oncol. 2009 Apr 20;27(12):2066-72. doi: 10.1200/JCO.2008.19.8366. Epub 2009 Mar 2.

18.

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

Turner BC, Knisely JP, Kacinski BM, Haffty BG, Gumbs AA, Roberts KB, Frank AH, Peschel RE, Rutherford TJ, Edraki B, Kohorn EI, Chambers SK, Schwartz PE, Wilson LD.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):77-84.

PMID:
9422561
19.

Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?

Ricci S, Giuntoli RL 2nd, Eisenhauer E, Lopez MA, Krill L, Tanner EJ 3rd, Gehrig PA, Havrilesky LJ, Secord AA, Levinson K, Frasure H, Celano P, Fader AN.

Gynecol Oncol. 2013 Dec;131(3):629-33. doi: 10.1016/j.ygyno.2013.08.037. Epub 2013 Sep 7.

PMID:
24016408
20.

Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.

Potikul C, Tangjitgamol S, Khunnarong J, Srijaipracharoen S, Thavaramara T, Pataradool K.

Asian Pac J Cancer Prev. 2016;17(4):1759-67.

Supplemental Content

Support Center